Susac's syndrome: an immune mediated endotheliopathy laden with challenges and controversies
- PMID: 23960147
- PMCID: PMC3762410
- DOI: 10.1136/bcr-2012-008390
Susac's syndrome: an immune mediated endotheliopathy laden with challenges and controversies
Abstract
Susac's syndrome is a microangiopathy of the retina, inner ear and brain manifesting as a triad of encephalopathy, hearing loss and branch retinal artery occlusion. The pathological mechanism is thought to be an immune-mediated small vessel vasculitis with some pathophysiological similarity to dermatomyositis. Awareness and early recognition of this syndrome is important as early treatment with immunosuppression can minimise cognitive, audiological and visual sequelae. We report a case of a 33-year-old woman who presented with the characteristic syndrome. She was treated with immunomodulatory therapy and remains well 2 years postpresentation with no new events.
Figures



References
-
- Henriques IL, Bogousslavsky J, Caplan LR. Microangiopathy of the retina, inner ear, and brain: Susac's syndrome. In: Caplan LR, ed. In uncommon causes of stroke. 2nd edn Cambridge University Press, 2008:247–54
-
- Rennebohm RM, Egan RA, Susac JO. Treatment of Susac's syndrome. Curr Treat Options Neurol 2008;2013:67–74 - PubMed
-
- Saux A, Niango G, Charif M, et al. Susac's syndrome, a rare, potentially severe or lethal neurological disease. J Neurol Sci 2010;2013:71–3 - PubMed
-
- Mersereau J. Gonadal failure with cyclophosphamide therapy for lupus nephritis: advances in fertility preservation. Rheum Dis Clin North Am 2010;2013:99–108, viii - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical